LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 225 participants.
Also called NCT04060914
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 225 participants
- Sponsor
- Registry
-
NCT04060914
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04060914. Randomized; no masking; primary purpose treatment. Start 2019-08-30 (anticipated); primary completion 2020-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
- Acronym
- LOTIC
- Condition
- Antiplatelet Therapy
- Condition
- Coronary Artery Disease
- Condition
- Percutaneous Coronary Intervention
- Intervention (Drug)
- Ticagrelor 90mg
- Intervention (Drug)
- Ticagrelor 90mg/60mg
- Intervention (Drug)
- Clopidogrel 75mg
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct04060914- Content hash
2665ab8801bab3e52e713027d07add3cc211fe1882be7df27523bcdccdf64e33